Apparatus

The collaboration aims to improve the efficiency of the drug discovery pipeline by leveraging industry-leading capabilities to identify genetic variants that cause human disease.

Misconceptions about how to treat a sore throat are fuelling the overuse of antibiotics, according to STAR research.

Elahere, the first antibody-coupled drug (ADC) for refractory ovarian cancer, has received accelerated approval from the FDA, resulting in substantial tumour shrinkage in 31.7% of patients and complete tumour disappearance in 4.8%.

HBM1020 is the world's first anti-B7H7 monoclonal antibody to be formally approved for clinical phase.

A new study has found that Istradefylline, a drug already approved to treat Parkinson's disease, not only reduces the toxicity associated with the chemotherapy drug cisplatin, but also boosts its cancer-fighting power, promising a potential treatment to reduce the side effects of chemotherapy.

The results of a new study recently showed that Olutasidenib monotherapy in patients with relapsed/refractory acute myeloid leukaemia carrying the IDH1 mutation elicited high rates of complete remission with manageable toxicity.

The "me better" strategy has always been a great story for pharmaceutical companies.

Medical engineers at Walter Reed National Military Medical Center are using additive manufacturing to develop customized prosthetic solutions for veterans. In fact, the center is even operating a 3D Medical Application Center (3DAC). There, a team of specialized engineers and 3D printing technicians are developing customized equipment according to the requirements of veterans.

Prior to the granting of marketing authorisation by the MHRA, Biyze® had been approved by the European Commission for a number of indications and is currently the only drug approved for the treatment of MZL in Great Britain.

New therapy for lung cancer!